Shares of Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $38.22, but opened at $41.51. Tempus AI shares last traded at $38.40, with a volume of 75,229 shares trading hands.
Analyst Ratings Changes
A number of research analysts have issued reports on the company. William Blair began coverage on Tempus AI in a research note on Tuesday, July 9th. They issued an “outperform” rating for the company. Longbow Research assumed coverage on Tempus AI in a research note on Tuesday, July 9th. They set a “buy” rating and a $48.00 target price for the company. Bank of America initiated coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They issued a “buy” rating and a $41.00 price target on the stock. Needham & Company LLC initiated coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set a “buy” rating and a $47.00 price objective on the stock. Finally, Stifel Nicolaus assumed coverage on shares of Tempus AI in a research note on Tuesday, July 9th. They issued a “buy” rating and a $45.00 target price for the company. Nine research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $45.63.
Tempus AI Stock Up 6.4 %
A number of hedge funds and other institutional investors have recently bought and sold shares of TEM. EFG Asset Management North America Corp. bought a new position in shares of Tempus AI in the second quarter valued at about $1,333,000. ARK Investment Management LLC acquired a new position in shares of Tempus AI in the second quarter valued at approximately $18,294,000. Northwestern University acquired a new position in shares of Tempus AI in the second quarter valued at approximately $491,000. Finally, Alphabet Inc. acquired a new stake in Tempus AI during the 2nd quarter worth approximately $54,289,000.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.